BioNTech
BNTX
BNTX
282 hedge funds and large institutions have $4.88B invested in BioNTech in 2023 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 92 increasing their positions, 88 reducing their positions, and 65 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
19% less capital invested
Capital invested by funds: $6.02B → $4.88B (-$1.14B)
51% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 65
62% less call options, than puts
Call options by funds: $114M | Put options by funds: $303M
Holders
282
Holding in Top 10
6
Calls
$114M
Puts
$303M
Top Buyers
| 1 | +$131M | |
| 2 | +$75.4M | |
| 3 | +$70M | |
| 4 |
Primecap Management
Pasadena,
California
|
+$55.1M |
| 5 |
Millennium Management
New York
|
+$47.9M |
Top Sellers
| 1 | -$99.3M | |
| 2 | -$93M | |
| 3 | -$92.9M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$57.5M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$45.5M |